Omentin-1 Suppressed Inflammation by NLRP3 through AMPK Function

被引:0
|
作者
Jiang, Yong [1 ]
Zhang, Dezhi [1 ]
He, Yi [1 ]
Wang, Jing [1 ]
Ma, Fei [1 ]
Sun, Junfu [1 ]
机构
[1] PLA Naval Anqing Hosp, Dept Neurol, 150 Shuangjing St, Anqing 246003, Anhui, Peoples R China
关键词
Acute Cerebral Infarction; AMP-Activated Protein Kinase; Cerebral Vessels; NOD-Like Receptor Family Pyrin Domain Containing 3; Omentin-1; CARDIOVASCULAR-DISEASE; BOWEL-DISEASE; RISK; MORTALITY;
D O I
10.31901/24566330.2022/22.03.830
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
This experiment investigated the biological roles of Omentin-1 in cerebral vessels of acute cerebral ischemia (ACI). The expressions of Omentin-1 in mouse model or patients with ACI were down-regulated. Moreover, Omentin-1 was negatively correlated with NIHSS score or serum IL-1 beta expression in patients undergoing intravenous thrombolysis for ACI. Omentin-1 was positively correlated with Barthel index in patients undergoing intravenous thrombolysis for ACI. In the mouse model or the in-vitro model, Omentin-1 mitigated inflammation factors. Additionally, in the in-vitro model of ACI, overexpression of Omentin-1 induced AMPK/ NLRP3 signaling pathway. Down-regulation of Omentin-1 also inhibited AMPK/ NLRP3 signaling pathway. Taken together, Omentin-1 suppressed ACI in the ACI model through inhibiting inflammation, which might serve as a potential treatment strategies of cardiovascular and cerebrovascular diseases in ACI.
引用
收藏
页码:185 / 197
页数:13
相关论文
共 50 条
  • [1] Omentin-1 May Be One Treatment Factor for Intravenous Thrombolysis of Acute Cerebral Infarction Through the Inhibition of NLRP3 Ubiquitination by AMPK Function: Preliminary Findings
    Xu, Junjiao
    Huang, Shiren
    NEUROLOGY INDIA, 2024, 72 (02) : 309 - 318
  • [2] Omentin-1 attenuates adipose tissue inflammation via restoration of TXNIP/NLRP3 signaling in high-fat diet-induced obese mice
    Zhou, Hongli
    Zhang, Zuo
    Qian, Guisheng
    Zhou, Jiyin
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2020, 34 (06) : 721 - 735
  • [3] Omentin-1 ameliorates oxidative stress in model of diabetic ophthalmopathy via the promotion of AMPK function
    Wang, Yan
    Hu, Qiang
    Luan, Lan
    Zhang, Hui
    MOLECULAR & CELLULAR TOXICOLOGY, 2022, 18 (04) : 477 - 485
  • [4] Omentin-1 ameliorates oxidative stress in model of diabetic ophthalmopathy via the promotion of AMPK function
    Yan Wang
    Qiang Hu
    Lan Luan
    Hui Zhang
    Molecular & Cellular Toxicology, 2022, 18 : 477 - 485
  • [5] Omentin-1 ameliorates pulmonary arterial hypertension by inhibiting endoplasmic reticulum stress through AMPKα signaling
    Deng, Xinyu
    Luo, Hao
    He, Jing
    Deng, Wang
    Wang, Daoxin
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2024, 46 (01)
  • [6] Circulating omentin-1 levels and inflammation in polycystic ovary syndrome
    Franik, Grzegorz
    Sadlocha, Marcin
    Madej, Pawel
    Owczarek, Aleksander
    Skrzypulec-Plinta, Violetta
    Plinta, Ryszard
    Chudek, Jerzy
    Olszanecka-Glinianowicz, Magdalena
    GINEKOLOGIA POLSKA, 2020, 91 (06) : 308 - 312
  • [7] Modulatory Role of Omentin-1 in Inflammation: Cytokines and Dietary Intake
    Zabetian-Targhi, Fateme
    Mirzaei, Khadijeh
    Keshavarz, Seyed Ali
    Hossein-Nezhad, Arash
    JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION, 2016, 35 (08) : 670 - 678
  • [8] Nobiletin Ameliorates NLRP3 Inflammasome-Mediated Inflammation Through Promoting Autophagy via the AMPK Pathway
    Haidong Wang
    Yujin Guo
    Yi Qiao
    Jun Zhang
    Pei Jiang
    Molecular Neurobiology, 2020, 57 : 5056 - 5068
  • [9] Nobiletin Ameliorates NLRP3 Inflammasome-Mediated Inflammation Through Promoting Autophagy via the AMPK Pathway
    Wang, Haidong
    Guo, Yujin
    Qiao, Yi
    Zhang, Jun
    Jiang, Pei
    MOLECULAR NEUROBIOLOGY, 2020, 57 (12) : 5056 - 5068
  • [10] Liraglutide attenuate central nervous inflammation and demyelination through AMPK and pyroptosis-related NLRP3 pathway
    Song, Shuang
    Guo, Ruoyi
    Mehmood, Arshad
    Zhang, Lu
    Yin, Bowen
    Yuan, Congcong
    Zhang, Huining
    Guo, Li
    Li, Bin
    CNS NEUROSCIENCE & THERAPEUTICS, 2022, 28 (03) : 422 - 434